PTC THERAPEUTICS, INC. — Director's Dealing 2019

Jan 24, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2019-01-22

Reporting Person: SCHMERTZLER MICHAEL (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-22	Stock Option (Right to Buy)	$33.02	A	28000	Acquired	2029-01-21	Common Stock (28000)	Direct

Footnotes

F1: This option was granted on January 22, 2019 and vests over one year in twelve equal monthly installments, commencing on February 22, 2019.